(Q42756928)

English

Melatonin promotes puromycin-induced apoptosis with activation of caspase-3 and 5'-adenosine monophosphate-activated kinase-alpha in human leukemia HL-60 cells

scientific article published on 18 January 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Melatonin promotes puromycin-induced apoptosis with activation of caspase-3 and 5'-adenosine monophosphate-activated kinase-alpha in human leukemia HL-60 cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

0 references

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

author name string

Wonil Koh

1

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Soo-Jin Jeong

2

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Hyo-Jung Lee

3

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Ho-Geon Ryu

4

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Eun-Ok Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Kyoo Seok Ahn

6

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Sung-Hoon Kim

8

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

publication date

18 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Journal of Pineal Research

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

50

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

367-373

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Melatonin: therapeutic and clinical utilization.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Melatonin: a multitasking molecule

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

A Review of the Multiple Actions of Melatonin on the Immune System

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Melatonin and doxorubicin synergistically induce cell apoptosis in human hepatoma cell lines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: potentiation of the extrinsic apoptotic pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Melatonin sensitizes human malignant glioma cells against TRAIL-induced cell death

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Leukemia cell lines: in vitro models for the study of acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Treatment of acute promyelocytic leukemia and other hematologic malignancies with arsenic trioxide: review of clinical and basic studies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

The "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Retinoic acid syndrome. Recognition, prevention and management

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Dissecting the role of 5'-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Management of cellular energy by the AMP-activated protein kinase system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Activation of AMP-activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and mTORC1 inhibition

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Apoptotic effect of quercetin on HT-29 colon cancer cells via the AMPK signaling pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Activation of the AMP-activated protein kinase-p38 MAP kinase pathway mediates apoptosis induced by conjugated linoleic acid in p53-mutant mouse mammary tumor cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Role of Chk1 and Chk2 in Ara-C-induced differentiation of human leukemia K562 cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Chk1 and Chk2 kinases in checkpoint control and cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Cell cycle checkpoint signaling through the ATM and ATR kinases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Inhibition of Chk1 by CEP-3891 accelerates mitotic nuclear fragmentation in response to ionizing Radiation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Chk2 regulates transcription-independent p53-mediated apoptosis in response to DNA damage.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Inhibition of cyclooxygenase-2-dependent survivin mediates decursin-induced apoptosis in human KBM-5 myeloid leukemia cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Tanshinone IIA induces mitochondria dependent apoptosis in prostate cancer cells in association with an inhibition of phosphoinositide 3-kinase/AKT pathway.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Acute Promyelocytc Leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Acute promyelocytic leukemia: from highly fatal to highly curable

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARalpha transcript after consolidation therapy: the Japan Adult Leukemia Study Group (JALSG) APL9

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Targeting AMPK: a new therapeutic opportunity in breast cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Metformin: taking away the candy for cancer?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

AMP-activated protein kinase mediates apoptosis in response to bioenergetic stress through activation of the pro-apoptotic Bcl-2 homology domain-3-only protein BMF

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Melatonin Potentiates the Neuroprotective Properties of Resveratrol Against Beta-Amyloid-Induced Neurodegeneration by Modulating AMP-Activated Protein Kinase Pathways

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Differential mode of regulation of the checkpoint kinases CHK1 and CHK2 by their regulatory domains

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

The E2F-regulated gene Chk1 is highly expressed in triple-negative estrogen receptor /progesterone receptor /HER-2 breast carcinomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Targeting the checkpoint kinase Chk1 in cancer therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Oxaliplatin responses in colorectal cancer cells are modulated by CHK2 kinase inhibitors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Cross-talk between Chk1 and Chk2 in double-mutant thymocytes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Melatonin: reducing the toxicity and increasing the efficacy of drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2010.00852.X

21 January 2018

Identifiers

10.1111/J.1600-079X.2010.00852.X

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42756928&oldid=1969305051"